vimarsana.com

Latest Breaking News On - Lynn baxter - Page 1 : vimarsana.com

FDA approves Dovato for teens living with HIV

FDA approves Dovato for teens living with HIV
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Lynn baxterDrug administrationNorth americaViiv healthcare

Dovato Approval Expanded to Include Adolescents Living With HIV

Dovato is a combination of dolutegravir, an integrase strand transfer inhibitor, and lamivudine, a nucleoside analogue reverse transcriptase inhibitor. The FDA has expanded the approval of Dovato (dolutegravir/lamivudine) to include treatment of HIV-1 infection in adolescents.

Lynn baxterDrug administrationNorth america

FDA approves ViiV Healthcare s Dovato for adolescent HIV treatment

FDA approves ViiV Healthcare s Dovato for adolescent HIV treatment
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Lynn baxterViiv healthcare

ViiV Healthcare announces U S FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV

DURHAM, N.C. (BUSINESS WIRE) Apr 8, 2024

United kingdomCity ofUnited kingdom generalUnited statesNorth carolinaLynn baxterSteph mountifieldJames dodwellMick readeyJosh williamsJeff mclaughlinAudrey abernathyCamilla campbellSarah clementsRachel jaikaranTim foley

FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

The treatment is indicated for adolescents at least 12 years of age who weigh at least 25 kg without a previous treatment history of antiretroviral therapies.

Lynn baxterViiv healthcareTherapy naive human immunodeficiencyNorth america

vimarsana © 2020. All Rights Reserved.